OptimizeRx Corporation (OPRX)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in OptimizeRx Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

OptimizeRx Corporation (OPRX) has returned -48.78% so far this year and -27.48% over the past 12 months. Looking at the last ten years, OPRX has achieved an annualized return of 18.92%, outperforming the S&P 500 Index benchmark, which averaged 12.16% per year.

Based on dividend-adjusted daily data since Jul 13, 2007, OPRX's average daily return is +21.72%, while the average monthly return is +463.41%. At this rate, your investment would double in approximately 0.0 years.

Historically, 45% of months were positive and 55% were negative. The best month was Apr 2008 with a return of +103,650.0%, while the worst month was Nov 2007 at -80.0%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 9 months.

On a daily basis, OPRX closed higher 38% of trading days. The best single day was Apr 28, 2008 with a return of +99,900.0%, while the worst single day was Jun 5, 2009 at -74.1%.

OptimizeRx Corporation has an annualized alpha of 356663966220882592923648.00%, beta of -1.25, and R² of 0.00 versus S&P 500 Index. Calculated based on daily prices since July 16, 2007.

• This stock captured 156.71% of S&P 500 Index gains and 115.63% of its losses — amplifying both gains and losses, but participating more in upside than downside.
• Beta of -1.25 may look defensive, but with R² of 0.00 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R² of 0.00 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

OPRX ranks 27 for risk / return — below 27% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.

The table below present risk-adjusted performance metrics for OptimizeRx Corporation (OPRX) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the OptimizeRx Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the OptimizeRx Corporation was 99.32%, occurring on Nov 29, 2007. Recovery took 102 trading sessions.

The current OptimizeRx Corporation drawdown is 93.59%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of OptimizeRx Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how OptimizeRx Corporation is priced in the market compared to other companies in the Health Information Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.